(Total Views: 300)
Posted On: 05/22/2020 10:37:24 AM
Post# of 36566
Sometimes I think Generex might be its own worse enemy. Looks like they put out 2 PRs, one right after the other.
The first was the big one, detailing the Patent, COVID-19, trial for Melanoma. The second one, is a small PR that says they Begun to plan a trial of the Peptide vaccine for Treatment of Melanoma.
So, the second one overshadows the first one that is detailed and has all the information, including what the second one has.
And at least on Fidelity, it's the second one that shows up last on the app. You have to go into GNBT and look at all the PRs to see what other PRs were sent.
Not sure why with the big news of the first, you send out a blurb PR right after.
The first was the big one, detailing the Patent, COVID-19, trial for Melanoma. The second one, is a small PR that says they Begun to plan a trial of the Peptide vaccine for Treatment of Melanoma.
So, the second one overshadows the first one that is detailed and has all the information, including what the second one has.
And at least on Fidelity, it's the second one that shows up last on the app. You have to go into GNBT and look at all the PRs to see what other PRs were sent.
Not sure why with the big news of the first, you send out a blurb PR right after.
(0)
(0)
